Download pdf
Research progress on calcium-activated potassium ion channels
- 1 College of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China
* Author to whom correspondence should be addressed.
Abstract
Potassium ion channels are diverse and widely distributed, playing a key role in a variety of physiological and pathological processes. According to the size of the conductance, they can be divided into large conductive calcium activated potassium channel (BK channel), medium conductive calcium activated potassium channel (IK channel) and small conductive calcium activated potassium channel (SK channel). In recent years, remarkable progress has been made in studying these three ion channels, and a series of therapeutic drugs have emerged. According to the single channel conductance, the BK channel, IK channel and SK channel, and the structure and functions of the three types of channels are introduced respectively. The main structure is composed of a tetrameric protein and a cavity in the center. These three types of potassium channels play a role in various clinical diseases, such as hypertension, Parkinson's, epilepsy and atrial fibrillation. Then in this paper for the existing three channels of therapeutic drugs and their mechanism is introduced and elaborated, more for some small molecule agonists, inhibitors and some toxin compounds, and also for the future research outlook-through the development of corresponding target regulator, reduce the side effects of drugs and adverse reactions, improve the bioavailability of new drugs. It is hoped that through the deeper study of such channels, clinically related diseases can be effectively solved and new breakthroughs can be achieved.
Keywords
BK channel, IK channel, SK channel, therapeutic drug.
[1]. Wang Y T, Guo X Y, Huang Z G, Wang S. Research progress on the structure and function of large conductance potassium ion channels (BK).[J] Advances in Biochemistry and Biophysics, 2015, 42(4):313-322.
[2]. Ramasubramanian, Smiruthi et al. The Structural Basis of IKs Ion-Channel Activation: Mechanistic Insights from Molecular Simulations. Biophysical Journal, Volume 114, Issue 11, 2584 – 2594.
[3]. Nam, YW., Downey, M., Rahman, M.A. et al. Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels. Acta Pharmacol Sin 44, 259–267 (2023).
[4]. Liu Ting, Li Tao, Xu Dandi, Wang Yan, Zhou Yafei, Wan Juyi, Huang Christopher L.-H. and Tan Xiaoqiu 2023Small-conductance calcium-activated potassium channels in the heart: expression, regulation and pathological implicationsPhil. Trans. R. Soc. B37820220171.
[5]. LiY Z, Zhang Y J.BKResearch progress on the regulatory role of channels in the nervous system[J].Henan Medical Research, 2020, 29(09):1728-1730.
[6]. LEE U S, CUI J.BK channel activation:structural and functional insights[J].Trends Neurosci2010, 33(9), 415-423.
[7]. Ling D Y, Wang L F, Wang Y, et al.BKAdvances in the field of cardiovascular disease[J].Medical Review, 2017, 23(09):1722-1727.
[8]. Wang Y C, Zhao Q Y.Mechanism of medium-conductive calcium activation of potassium channels in the development of atrial fibrillation[J].Chinese Journal of Cardiac Pacing and Cardiac Electrophysiology, 2022, 36(01):61-64.
[9]. Zhao LM, Zhang W, Wang L P et al. Advanced glycation end products promote proliferation of cardiac fibroblastsby upregulation of KCa3.1 channels[J]. Pflugers Arch, 2012, 464(6):613.
[10]. Wang L P Wang Y, Zhao L M et al. Angiotensin Il upregulates KCa3.1 channels and stimulates cell prolferation in rat cardiac fibroblasts[J].Biochem Pharmacol, 2013, 85(10):1 486.
[11]. Martin, S., Lazzarini, M., Dullin, C. et al. SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments [J]. Mol Neurobiol, 2017, 54, 1078–1091.
[12]. Egorova P A, Bezprozvanny I B. Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2 [J]. Cerebellum, 2022, 21(5): 742-749.
[13]. Shamsaldeen YA, Culliford L, James AF, et al.Role of SK channel activation in determining the action potential configuration in freshly isolated human atrial myocytes from the SKArF study, Biochemical and Biophysical Research Communications, 2019;512(4); 684-690.
[14]. Gu M, Zhu Y, Yin X, et al. Small-conductance Ca2+-activated K+channels: insights into their roles in cardiovascular disease [J]. Exp Mol Med, 2018, 50(4): 1-7.
[15]. Michael E. Rockman, Alexandre G. Vouga, Brad S. Rothberg; Molecular mechanism of BK channel activation by the smooth muscle relaxant NS11021. J Gen Physiol 1 June 2020; 152 (6).
[16]. Rupal P. Soder, Georgi V. Petkov, et al. Large conductance Ca2+-activated K+ channel activation with NS1619 decreases myogenic and neurogenic contractions of rat detrusor smooth muscle, European Journal of Pharmacology, 2011, 670(1);252-259.
[17]. Ran Guo, Miao Cui, Xiaojing Li, et al. Design, synthesis and biological evaluation of pyrrolopyrimidine derivatives as novel and selective positive modulator of the small conductance Ca2+-activated K+ channels, European Journal of Medicinal Chemistry, 2023, 254; 0223-5234.
Cite this article
Chen,X. (2024). Research progress on calcium-activated potassium ion channels. Theoretical and Natural Science,62,160-165.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).